0001209191-14-077687.txt : 20141223
0001209191-14-077687.hdr.sgml : 20141223
20141223145443
ACCESSION NUMBER: 0001209191-14-077687
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20141222
FILED AS OF DATE: 20141223
DATE AS OF CHANGE: 20141223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001273636
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 593553710
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 11801 RESEARCH DRIVE
STREET 2: SUITE D
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: 386-462-2204
MAIL ADDRESS:
STREET 1: 11801 RESEARCH DRIVE
STREET 2: SUITE D
CITY: ALACHUA
STATE: FL
ZIP: 32615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Menichella Daniel L
CENTRAL INDEX KEY: 0001472131
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36370
FILM NUMBER: 141306375
MAIL ADDRESS:
STREET 1: 79 TW ALEXANDER DRIVE
STREET 2: 4101 RESEARCH COMMONS
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-22
0
0001273636
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
0001472131
Menichella Daniel L
C/O APPLIED GENETIC TECHNOLOGIES CORP.
11801 RESEARCH DRIVE, SUITE D
ALACHUA
FL
32615
0
1
0
0
V.P. & Chief Business Officer
Common Stock
2014-12-22
4
M
0
9000
4.90
A
9000
D
Common Stock
2014-12-22
4
S
0
9000
20.83
D
0
D
Stock Option (Right to Buy)
4.90
2014-12-22
4
M
0
9000
0.00
D
2023-09-18
Common Stock
9000
117968
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.6535 to $21.01, inclusive. The reporting person undertakes to provide Applied Genetic Technologies Corporation, any security holder in Applied Genetic Technologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The option, representing a right to purchase a total of 126,968 shares, became exercisable for 25% of the underlying shares on September 18, 2014, and thereafer becomes exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option becoming exercisable for 100% of the underlying shares on the fourth anniversary of the date of grant.
/s/ Hemmie Chang, attorney-in-fact for Daniel Menichella
2014-12-23
EX-24.4_550997
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that the undersigned hereby authorizes Hemmie Chang
and Robert W. Sweet, Jr., each of Foley Hoag LLP, to execute for and on behalf
of the undersigned, in the undersigned's capacity as an officer of Applied
Genetic Technologies Corporation (the "Company"), a Form ID, Forms 3, 4 and 5,
and any amendments thereto, and cause such form(s) to be filed with the United
States Securities and Exchange Commission pursuant to Section 16(a) of the
Securities Act of 1934, relating to the undersigned's beneficial ownership of
securities in the Company. The undersigned hereby grants to the attorney-in-fact
full power and authority to do and perform any and every act and thing
whatsoever requisite, necessary or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and purposes as
the undersigned might or could do personally present, with full power of
substitution, resubstitution or revocation, hereby ratifying and confirming all
that such attorney-in-fact, or such attorney's-in-fact substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorney-in-fact, in serving in such capacity at the request
of the undersigned, is not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of, and transactions in, securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 12th day of January, 2014.
/s/ Daniel Menichella
Daniel Menichella